171 related articles for article (PubMed ID: 35040075)
21. Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma.
Leon-Ferre RA; Kottschade LA; Block MS; McWilliams RR; Dronca RS; Creagan ET; Allred JB; Lowe VJ; Markovic SN
Melanoma Res; 2017 Aug; 27(4):335-341. PubMed ID: 28296712
[TBL] [Abstract][Full Text] [Related]
22. The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery.
Okamura R; Hasegawa S; Hida K; Hoshino N; Kawada K; Sugihara K; Sakai Y;
Int J Clin Oncol; 2017 Feb; 22(1):96-101. PubMed ID: 27503134
[TBL] [Abstract][Full Text] [Related]
23. Assessing surveillance utilization and value in commercially insured patients with colorectal cancer.
Suh K; Shankaran V; Bansal A
Am J Manag Care; 2022 May; 28(5):e163-e169. PubMed ID: 35546589
[TBL] [Abstract][Full Text] [Related]
24. Adherence to postresection colorectal cancer surveillance at National Cancer Institute-designated Comprehensive Cancer Centers.
Kupfer SS; Lubner S; Coronel E; Pickhardt PJ; Tipping M; Graffy P; Keenan E; Ross E; Li T; Weinberg DS
Cancer Med; 2018 Nov; 7(11):5351-5358. PubMed ID: 30338661
[TBL] [Abstract][Full Text] [Related]
25. Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.
Caglar M; Yener C; Karabulut E
Int J Comput Assist Radiol Surg; 2015 Jul; 10(7):993-1002. PubMed ID: 25213271
[TBL] [Abstract][Full Text] [Related]
26. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
28. FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA.
Sarikaya I; Bloomston M; Povoski SP; Zhang J; Hall NC; Knopp MV; Martin EW
World J Surg Oncol; 2007 Jun; 5():64. PubMed ID: 17555577
[TBL] [Abstract][Full Text] [Related]
29. Care of Cancer Survivors: Special Issues for Colorectal Cancer Survivors.
Gorin SS
FP Essent; 2023 Jun; 529():23-33. PubMed ID: 37307154
[TBL] [Abstract][Full Text] [Related]
30. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study.
Ozkan E; Soydal C; Araz M; Aras G
Nucl Med Commun; 2012 Sep; 33(9):990-4. PubMed ID: 22842225
[TBL] [Abstract][Full Text] [Related]
31. Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival?
Lechner P; Lind P; Goldenberg DM
J Am Coll Surg; 2000 Nov; 191(5):511-8. PubMed ID: 11085731
[TBL] [Abstract][Full Text] [Related]
32. Does serum carcinoembryonic antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III.
Hara M; Sato M; Takahashi H; Takayama S; Takeyama H
J Surg Oncol; 2010 Aug; 102(2):154-7. PubMed ID: 20648586
[TBL] [Abstract][Full Text] [Related]
33. Strict follow-up programme including CT and ¹⁸F-FDG-PET after curative surgery for colorectal cancer.
Sørensen NF; Jensen AB; Wille-Jørgensen P; Friberg L; Rørdam L; Ingeman L; Hennild V
Colorectal Dis; 2010 Oct; 12(10 Online):e224-8. PubMed ID: 20002699
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer.
Fakih M; Sandhu J; Wang C; Kim J; Chen YJ; Lai L; Melstrom K; Kaiser A
JAMA Netw Open; 2022 Mar; 5(3):e221093. PubMed ID: 35258578
[TBL] [Abstract][Full Text] [Related]
35. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study.
Monteil J; Le Brun-Ly V; Cachin F; Zasadny X; Seitz JF; Mundler O; Selvy M; Smith D; Rullier E; Lavau-Denes S; Lades G; Labrunie A; Lecaille C; Valli N; Leobon S; Terrebonne E; Deluche E; Tubiana-Mathieu N
Dig Liver Dis; 2021 Feb; 53(2):231-237. PubMed ID: 33153929
[TBL] [Abstract][Full Text] [Related]
37. Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.
Vallam KC; Guruchannabasavaiah B; Agrawal A; Rangarajan V; Ostwal V; Engineer R; Saklani A
Colorectal Dis; 2017 Oct; 19(10):907-911. PubMed ID: 28444968
[TBL] [Abstract][Full Text] [Related]
38. Why recurrence was initially suspected during colorectal cancer postoperative surveillance?: A retrospective analysis.
Hung H; You J; Chiang J; Hsieh P; Chiang S; Lai C; Tasi W; Yeh C
Medicine (Baltimore); 2020 Oct; 99(43):e22803. PubMed ID: 33120800
[TBL] [Abstract][Full Text] [Related]
39. Surveillance approaches among colorectal cancer survivors after curative-intent.
Haggstrom DA; Imperiale TF
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):483-500. PubMed ID: 19942831
[TBL] [Abstract][Full Text] [Related]
40. Follow-up after curative resection of colorectal cancer.
Fahy BN
Ann Surg Oncol; 2014 Mar; 21(3):738-46. PubMed ID: 24271157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
